1-4 of 4
Hans Pruijt
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cell-Free DNA Genomic and Fragmentomic Features for Early Outcome Prediction in Diffuse Large B-Cell Lymphoma

Steven Wang, Parisa Mapar, Ymke van der Pol, Norbert Moldovan, Normastuti Adhini Tantyo, Erik D. van Werkhoven, Bart Snieder, André Do Brito Valente, A. De Jonge, Esther Drees, Margaretha G.M. Roemer, Bauke Ylstra, Clara Klerk, Leonie Strobbe, Yorick Sandberg, Rinske Boersma, Harry R. Koene, Hans Pruijt, Koen de Heer, Rozemarijn van Rijn, Yavuz M. Bilgin, Eva De Jongh, Marcel Nijland, Marjolein W.M. van der Poel, Ad Koster, Laurens Nieuwenhuizen, Rob Fijnheer, Aart Beeker, Rogier Mous, Vibeke KJ Vergote, Joost S.P. Vermaat, Dirk Michiel Pegtel, Martine E.D. Chamuleau, Florent Mouliere
Journal: Blood
Blood (2024) 144 (Supplement 1): 1588.
https://doi.org/10.1182/blood-2024-206636
Published: 2024
Journal Articles

A Phase I Study of Allogeneic Natural Killer Cell Therapy Generated from Cord Blood Hematopoietic Stem and Progenitor Cells in Elderly Acute Myeloid Leukemia Patients

Harry Dolstra, PhD, Mieke W.H. Roeven, MD, Jan Spanholtz, PhD, Basav Hangalapura, PhD, Marleen Tordoir, Frans Maas, Marij Leenders, Fenna Bohme, Nina Kok, Carel Trilsbeek, Jos Paardekooper, Anniek B. Van der Waart, PhD, Peter Westerweel, MD PhD, Tjeerd J.F. Snijders, MD, Gerard M.J. Bos, MD PhD, Jan J. Cornelissen, MD PhD, Hans Pruijt, MD PhD, Gerwin Huls, MD PhD, Aniek de Graaf, PhD, Bert A. van der Reijden, PhD, Nicole M.A. Blijlevens, MD PhD, Joop H. Jansen, PhD, Arnold van der Meer, PhD, Jeannette Cany, PhD, Frank Preijers, PhD, Nicolaas P.M. Schaap, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1357.
https://doi.org/10.1182/blood.V126.23.1357.1357
Published: 2015
Journal Articles

Clofarabine in Combination with a Standard Remission Induction Regimen in Patients 18-60 Years Old with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Combined Phase I/II Results of the EORTC/Gimema AML-14A Trial

Dominik L.D. Selleslag, MD, Stefan Suciu, Giovanna Meloni, MD, Petra Muus, MD PhD, Constantijn J.M. Halkes, MD PhD, Adriano Venditti, MD, Safaa M Ramadan, MD PhD, Hans Pruijt, MD PhD, Liv Meert, MSc, Marco Vignetti, MD, Jean-Pierre Marie, MD, Dominique Bron, MD PhD, Theo de Witte, MD, Sergio Amadori, MD, Roelof Willemze, MD PhD, Frederic Baron, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3675.
https://doi.org/10.1182/blood.V124.21.3675.3675
Published: 2014
Journal Articles

Interim Analysis on a Dutch HOVON Multicenter Randomized Open Label Phase II Trial on 3 Rituximab Dosing Schemes In Chronic ITP Patients:

Jaap Jan Zwaginga, MD, PhD, Ronnie van der Holt, PhD, Bart J. Biemond, MD, PhD, Peter A.W. te Boekhorst, MD, PhD, Mark Levin, MD, PhD, Art Vreughdenhil, MD, PhD, P.C. Huijgens, MD, PhD, Anneke Brand, MD, PhD, Rene van der Griend, MD, PhD, Marleen Luten, Hans Pruijt, MD, PhD, Okke de Weerdt, Elisabeth van Pampus, MD, PhD, Sonja Zweegman, MD, PhD, Rene Hollestein, Harry R. Koene, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2514.
https://doi.org/10.1182/blood.V116.21.2514.2514
Published: 2010